Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively... Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. 더 보기
– Company plans to provide seizure as well as cognition and behavior data from all patients treated with initial 70mg doses followed by 45mg maintenance dosing in studies of zorevunersen by...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.45 | -17.65129683 | 13.88 | 13.95 | 11.08 | 620159 | 11.77669135 | CS |
4 | -0.62 | -5.14522821577 | 12.05 | 14.72 | 11.08 | 470574 | 12.72636435 | CS |
12 | -2.56 | -18.2987848463 | 13.99 | 16.15 | 11.08 | 577536 | 13.27278366 | CS |
26 | -3.91 | -25.4889178618 | 15.34 | 17.58 | 11.08 | 586669 | 13.94523064 | CS |
52 | 7.51 | 191.581632653 | 3.92 | 17.58 | 3.77 | 691928 | 12.20394904 | CS |
156 | -17.87 | -60.9897610922 | 29.3 | 33.0635 | 3.35 | 429327 | 12.21637641 | CS |
260 | -11.45 | -50.0437062937 | 22.88 | 71.58 | 3.35 | 319063 | 16.39998724 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관